MedPath

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Phase 4
Recruiting
Conditions
Osteomyelitis Tibia
Tibial Fractures
Open Tibia Fracture
Interventions
Other: Standard Intramedullary Nail
Drug: Antibiotic coated intramedullary Nail
Registration Number
NCT05421741
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.

Detailed Description

Despite significant treatment advances and protocols to prevent infection, severe open fractures of the lower extremity still have very high rates of deep infection. Infection in an active duty military population increases disability and decreases the likelihood of returning to duty. In addition, infection is one of the main factors associated with rehospitalization. Further, deep infections have not only resulted in increased disability after injury, infection is implicated as one of the main factors in late amputation. Among service members, only 20-25% with a severe open tibia fracture are able to return to active duty. Novel techniques for reducing infection are needed. The proposed study addresses the focus area of fracture-related infections, specifically the prevention of infection.

This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.

This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.

The target population for the proposed study is patients with severe open tibia fractures (Type II or Type III) who require definitive fixation with intramedullary nail recruited from one of the participating sites during the index hospitalization.

One group will be treated prophylactically using an antibiotic coated intramedullary nail at time of definitive fixation (1CN), while the second group will be treated with traditional standard of care intramedullary nail without antibiotic-coating (SN).

Participant will be followed for 12 months (data capture including patient interviews and clinical data capture from the treatment team and medical record at baseline, 6 weeks, 3 months, 6 months, and 12 months).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
484
Inclusion Criteria
  • Patients 18 years or older
  • Gustilo Type II or III open tibia fracture requiring definitive fixation with intramedullary nail
Exclusion Criteria
  • Less than 18 years of age
  • Allergy to vancomycin or gentamicin
  • Unable to speak English or Spanish
  • Pregnant and lactating women
  • Prisoner
  • Unable to follow up for 12 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intramedullary NailStandard Intramedullary NailTraditional standard of care intramedullary (IM) nail
Antibiotic Coated Intramedullary NailAntibiotic coated intramedullary NailIntramedullary Nail coated with 2 grams of vancomycin and 560 mg gentamicin liquid.
Primary Outcome Measures
NameTimeMethod
Number of Participants who develop deep surgical site infection (SSI)Day 30 through month 12

Number of participants in each group who develop SSI as defined by the criteria establish by the Centers for Disease Control and Prevention (CDC). The CDC criteria define deep as occurring within 30 or 90 days after the procedure. However, we will continue to follow patients for 12 months and document any infections and other complications during this period.

Secondary Outcome Measures
NameTimeMethod
Number of Subjects Who Have Returned to Workweek 6, month 3, month 6 and month12

Determined by asking whether subjects have returned to work

Number of Participants who Return to Operating Room (OR)Month 12
International Physical Activity Questionnaire (IPAQ)week 6, month 3, month 6 and month12

IPAQ measures the total amount of physical activity completed in a 7 day period by calculating the minutes per week in in each physical activity level domain (walking, moderate and vigorous) by a metabolic equivalent energy (MET) expenditure estimate.

Walking = 3.3 x number of walking minutes x number of walking days Moderate activity= 4.0 x number activity minutes x number of days Vigorous activity = 8 x number of activity minutes x number of days Total = Walking MET-min/wk+moderate MET-min/wk+vigorous MET-min/wk

PROMIS-29 Subscale--Depressionweek 6, month 3, month 6 and month12

The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of depression.

PROMIS-29 Subscale--Fatigueweek 6, month 3, month 6 and month12

The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of fatigue.

Percentage of Unionweek 6, month 3, month 6 and month12

Union is the gradual process of bone regeneration after a fracture. Percentage of Union, as determined by the treating surgeon, will be assessed via radiographs. Recorded by surgeon as yes/no answers.

Time to Unionweek 6, month 3, month 6 and month12

Captured in days

Average Time to Return to Work/Dutyweek 6, month 3, month 6 and month12

number of days

PROMIS-29 Subscale--Physical Functionweek 6, month 3, month 6 and month12

The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means higher physical function.

PROMIS-29 Subscale--Sleep Disturbanceweek 6, month 3, month 6 and month12

The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of sleep disturbance.

Radiographic Union Scale in Tibial fractures (RUST) scoreweek 6, month 3, month 6, and month 12

The RUST score ranges from a minimum score of 4 (definitely not healed) to a maximum score of 12 (completely healed). The final x-ray obtained within a 12-month period following injury will be uploaded to REDCap for review by a blinded panel of investigators from participating sites.

PROMIS-29 Subscale--Pain Interferenceweek 6, month 3, month 6 and month12

The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of pain interference.

PROMIS-29 Subscale--Ability to Participate in Social Roles and Activitiesweek 6, month 3, month 6 and month12

The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher ability to participate in social roles and activities.

PROMIS-29 Subscale--Physical Function: Anxietyweek 6, month 3, month 6 and month12

The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation. Higher scores means a higher level of anxiety.

Trial Locations

Locations (14)

University of Florida Gainesville

šŸ‡ŗšŸ‡ø

Gainesville, Florida, United States

Florida Orthopaedic Institute

šŸ‡ŗšŸ‡ø

Temple Terrace, Florida, United States

Atrium Health Navicent

šŸ‡ŗšŸ‡ø

Macon, Georgia, United States

University of Kentucky

šŸ‡ŗšŸ‡ø

Lexington, Kentucky, United States

Louisiana State University - University Medical Center New Orleans

šŸ‡ŗšŸ‡ø

New Orleans, Louisiana, United States

University of North Carolina Chapel Hill

šŸ‡ŗšŸ‡ø

Chapel Hill, North Carolina, United States

Atrium Health Carolinas Medical Center

šŸ‡ŗšŸ‡ø

Charlotte, North Carolina, United States

Atrium Health Cabarrus

šŸ‡ŗšŸ‡ø

Concord, North Carolina, United States

Atrium Health Wake Forest Baptist

šŸ‡ŗšŸ‡ø

Winston-Salem, North Carolina, United States

Penn State Milton S. Hershey Medical Center

šŸ‡ŗšŸ‡ø

Hershey, Pennsylvania, United States

Vanderbilt University Medical Center

šŸ‡ŗšŸ‡ø

Nashville, Tennessee, United States

University of Texas Houston

šŸ‡ŗšŸ‡ø

Houston, Texas, United States

San Antonio Military Medical Center

šŸ‡ŗšŸ‡ø

San Antonio, Texas, United States

Valley Health System

šŸ‡ŗšŸ‡ø

Winchester, Virginia, United States

Ā© Copyright 2025. All Rights Reserved by MedPath